Abstract
The focus of this chapter are different disorders of primary renal salt-wasting caused by inherited dysfunction of ion-transporting proteins expressed along the thick ascending limb (TAL) of Henle’s loop and along the early distal convoluted tubule (DCT). The clinical presentation, the underlying pathophysiology resulting from the different gene defects and the therapeutic approaches for the different subtypes of Bartter syndrome, Gitelman syndrome and EAST syndrome will be discussed in detail. Renal salt-wasting due to impaired sodium reabsorption along the aldosterone-sensitive distal nephron (ASDN) composed of the late DCT, the connecting tubule (CNT), and the collecting duct (CD) is accompanied by hyperkalemia and is discussed elsewhere.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jeck N, Schlingmann KP, Reinalter SC, et al. Salt handling in the distal nephron: lessons learned from inherited human disorders. Am J Physiol Regul Integr Comp Physiol. 2005;288(4):R782–95.
Rosenbaum P, Hughes M. Persistent, probably congenital, hypokalemic metabolic alkalosis with hyaline degeneration of renal tubules and normal urinary aldosterone. Am J Dis Child. 1957;94:560.
Bartter FC, Pronove P, Gill JR, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med. 1962;33:811–28.
Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians. 1966;79:221–35.
Rodriguez-Soriano J, Vallo A, Garcia-Fuentes M. Hypomagnesaemia of hereditary renal origin. Pediatr Nephrol. 1987;1(3):465–72.
Bettinelli A, Bianchetti MG, Girardin E, et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr. 1992;120(1):38–43.
Bartter FC, Pronove P, Gill JR Jr, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. 1962. J Am Soc Nephrol. 1998;9(3):516–28.
Fanconi A, Schachenmann G, Nüssli R, Prader A. Chronic hypokalaemia with growth retardation, normotensive hyperrenin-hyperaldosteronism (“Bartter’s syndrome”), and hypercalciuria. Report of two cases with emphasis on natural history and on catch-up growth during treatment. Helv Paediatr Acta. 1971;26(2):144–63.
McCredie DA, Blair-West JR, Scoggins BA, Shipman R. Potassium-losing nephropathy of childhood. Med J Aust. 1971;1(3):129–35.
Ohlsson A, Sieck U, Cumming W, Akhtar M, Serenius F. A variant of Bartter’s syndrome. Bartter’s syndrome associated with hydramnios, prematurity, hypercalciuria and nephrocalcinosis. Acta Paediatr Scand. 1984;73(6):868–74.
Seyberth HW, Rascher W, Schweer H, Kühl PG, Mehls O, Schärer K. Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr. 1985;107(5):694–701.
Seyberth HW, Königer SJ, Rascher W, Kühl PG, Schweer H. Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders. Pediatr Nephrol. 1987;1(3):491–7.
Landau D, Shalev H, Ohaly M, Carmi R. Infantile variant of Bartter syndrome and sensorineural deafness: a new autosomal recessive disorder. Am J Med Genet. 1995;59(4):454–9.
Laghmani K, Beck BB, Yang SS, et al. Polyhydramnios, transient antenatal Bartter’s syndrome, and MAGED2 mutations. N Engl J Med. 2016;374(19):1853–63.
Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP. Bartter’s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet. 1996;13(2):183–8.
Simon DB, Karet FE, Rodriguez-Soriano J, et al. Genetic heterogeneity of Bartter’s syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet. 1996;14(2):152–6.
Birkenhäger R, Otto E, Schürmann MJ, et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet. 2001;29(3):310–4.
Schlingmann KP, Konrad M, Jeck N, et al. Salt wasting and deafness resulting from mutations in two chloride channels. N Engl J Med. 2004;350(13):1314–9.
Simon DB, Bindra RS, Mansfield TA, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter’s syndrome type III. Nat Genet. 1997;17(2):171–8.
Simon DB, Nelson-Williams C, Bia MJ, et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996;12(1):24–30.
Watanabe S, Fukumoto S, Chang H, et al. Association between activating mutations of calcium-sensing receptor and Bartter’s syndrome. Lancet. 2002;360(9334):692–4.
Hebert SC. Bartter syndrome. Curr Opin Nephrol Hypertens. 2003;12(5):527–32.
Bockenhauer D, Feather S, Stanescu HC, et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med. 2009;360(19):1960–70.
Scholl UI, Choi M, Liu T, et al. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Natl Acad Sci U S A. 2009;106(14):5842–7.
Simon DB, Lu Y, Choate KA, et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science. 1999;285(5424):103–6.
Konrad M, Schaller A, Seelow D, et al. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet. 2006;79(5):949–57.
Kamel KS, Oh MS, Halperin ML. Bartter’s, Gitelman’s, and Gordon’s syndromes. From physiology to molecular biology and back, yet still some unanswered questions. Nephron. 2002;92(Suppl 1):18–27.
Jeck N, Derst C, Wischmeyer E, et al. Functional heterogeneity of ROMK mutations linked to hyperprostaglandin E syndrome. Kidney Int. 2001;59(5):1803–11.
Finer G, Shalev H, Birk OS, et al. Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome. J Pediatr. 2003;142(3):318–23.
Peters M, Jeck N, Reinalter S, et al. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med. 2002;112(3):183–90.
Konrad M, Vollmer M, Lemmink HH, et al. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol. 2000;11(8):1449–59.
Zelikovic I, Szargel R, Hawash A, et al. A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int. 2003;63(1):24–32.
Estévez R, Boettger T, Stein V, et al. Barttin is a Cl- channel beta-subunit crucial for renal Cl− reabsorption and inner ear K+ secretion. Nature. 2001;414(6863):558–61.
Waldegger S, Jeck N, Barth P, et al. Barttin increases surface expression and changes current properties of ClC-K channels. Pflugers Arch. 2002;444(3):411–8.
Jeck N, Reinalter SC, Henne T, et al. Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness. Pediatrics. 2001;108(1):E5.
Engels A, Gordjani N, Nolte S, Seyberth HW. Angeborene passagere hyperprostaglandinurische Tubulopathie bei zwei frühgeborenen Geschwistern. Mschr Kinderheilk. 1991;139:185.
Reinalter S, Devlieger H, Proesmans W. Neonatal Bartter syndrome: spontaneous resolution of all signs and symptoms. Pediatr Nephrol. 1998;12(3):186–8.
Legrand A, Treard C, Roncelin I, et al. Prevalence of novel. Clin J Am Soc Nephrol. 2018;13(2):242–50.
Zhang C, Wang L, Zhang J, et al. KCNJ10 determines the expression of the apical Na-Cl cotransporter (NCC) in the early distal convoluted tubule (DCT1). Proc Natl Acad Sci U S A. 2014;111(32):11864–9.
Neusch C, Rozengurt N, Jacobs RE, Lester HA, Kofuji P. Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination. J Neurosci. 2001;21(15):5429–38.
Scholl UI, Dave HB, Lu M, et al. SeSAME/EAST syndrome—phenotypic variability and delayed activity of the distal convoluted tubule. Pediatr Nephrol. 2012;27(11):2081–90.
Rodriguez-Soriano J. Bartter’s syndrome comes of age. Pediatrics. 1999;103(3):663–4.
Vaisbich MH, Fujimura MD, Koch VH. Bartter syndrome: benefits and side effects of long-term treatment. Pediatr Nephrol. 2004;19(8):858–63.
Reinalter SC, Jeck N, Brochhausen C, et al. Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int. 2002;62(1):253–60.
Shalev H, Ohali M, Kachko L, Landau D. The neonatal variant of Bartter syndrome and deafness: preservation of renal function. Pediatrics. 2003;112(3 Pt 1):628–33.
Zaffanello M, Taranta A, Palma A, Bettinelli A, Marseglia GL, Emma F. Type IV Bartter syndrome: report of two new cases. Pediatr Nephrol. 2006;21(6):766–70.
Chaudhuri A, Salvatierra O, Alexander SR, Sarwal MM. Option of pre-emptive nephrectomy and renal transplantation for Bartter’s syndrome. Pediatr Transplant. 2006;10(2):266–70.
Knoers NV. Gitelman syndrome. Adv Chronic Kidney Dis. 2006;13(2):148–54.
Rodríguez-Soriano J. Bartter and related syndromes: the puzzle is almost solved. Pediatr Nephrol. 1998;12(4):315–27.
Shaer AJ. Inherited primary renal tubular hypokalemic alkalosis: a review of Gitelman and Bartter syndromes. Am J Med Sci. 2001;322(6):316–32.
Riveira-Munoz E, Chang Q, Godefroid N, et al. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol. 2007;18(4):1271–83.
Godefroid N, Riveira-Munoz E, Saint-Martin C, Nassogne MC, Dahan K, Devuyst O. A novel splicing mutation in SLC12A3 associated with Gitelman syndrome and idiopathic intracranial hypertension. Am J Kidney Dis. 2006;48(5):e73–9.
Colussi G, Rombola G, De Ferrari ME, Macaluso M, Minetti L. Correction of hypokalemia with antialdosterone therapy in Gitelman’s syndrome. Am J Nephrol. 1994;14(2):127–35.
Blanchard A, Vargas-Poussou R, Vallet M, et al. Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome. J Am Soc Nephrol. 2015;26(2):468–75.
Bettinelli A, Tosetto C, Colussi G, Tommasini G, Edefonti A, Bianchetti MG. Electrocardiogram with prolonged QT interval in Gitelman disease. Kidney Int. 2002;62(2):580–4.
Foglia PE, Bettinelli A, Tosetto C, et al. Cardiac work up in primary renal hypokalaemia-hypomagnesaemia (Gitelman syndrome). Nephrol Dial Transplant. 2004;19(6):1398–402.
Cruz DN, Shaer AJ, Bia MJ, Lifton RP, Simon DB, Yale Gitelman’s and Bartter’s Syndrome Collaborative Study Group. Gitelman’s syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int. 2001;59(2):710–7.
Bonfante L, Davis PA, Spinello M, et al. Chronic renal failure, end-stage renal disease, and peritoneal dialysis in Gitelman’s syndrome. Am J Kidney Dis. 2001;38(1):165–8.
Calò LA, Marchini F, Davis PA, Rigotti P, Pagnin E, Semplicini A. Kidney transplant in Gitelman’s syndrome. Report of the first case. J Nephrol. 2003;16(1):144–7.
Konrad M, Nijenhuis T, Ariceta G, et al. Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders. Kidney Int. 2021;99(2):324–35.
Blanchard A, Bockenhauer D, Bolignano D, et al. Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2017;91(1):24–33.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Waldegger, S., Schlingmann, K.P., Konrad, M. (2023). Bartter-, Gitelman-, and Related Syndromes. In: Schaefer, F., Greenbaum, L.A. (eds) Pediatric Kidney Disease. Springer, Cham. https://doi.org/10.1007/978-3-031-11665-0_36
Download citation
DOI: https://doi.org/10.1007/978-3-031-11665-0_36
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-11664-3
Online ISBN: 978-3-031-11665-0
eBook Packages: MedicineMedicine (R0)